Patients | N. 102 | % | |||
---|---|---|---|---|---|
Gender | |||||
Female | 39 | 38 | |||
Male | 63 | 62 | |||
Age (median) | 61 years (range 30–93 years) | ||||
Histology | |||||
Breast Cancer | 18 | 17 | |||
NSCLC | 57 | 56 | |||
Melanoma | 12 | 12 | |||
Other (CCC, Colon) | 15 | 15 | |||
Stage at diagnosis of primary tumor | |||||
I–III | 51 | 50 | |||
IV | 51 | 50 | |||
KPS at BM diagnosis | |||||
100 | 18 | 17 | |||
90 | 18 | 17 | |||
80 | 63 | 63 | |||
70 | 3 | 3 | |||
RPA class | |||||
I | 18 | 18 | |||
II | 81 | 79 | |||
III | 3 | 3 | |||
GPA score | 0–1 | 1.5–2.5 | 3 | 3.5–4 | |
Breast cancer | 0 | 6 | 12 | 0 | |
NSCLC | 12 | 36 | 3 | 6 | |
Melanoma | 0 | 0 | 6 | 6 | |
Other | 0 | 12 | 3 | 0 | |
Other extracranial metastatic site at diagnosis of BM | 66 | 65 | |||
BM median maximum diameter cm (range cm) | 2.9 (2.1–5) | ||||
BM diameter cm | |||||
2.1–3 cm | 51 | 50 | |||
3.1–5 cm | 51 | 50 | |||
GTV median volume cm3 (range cm3) | 16.3 (3.9–64.5) | ||||
PTV median volume cm3 (range cm3) | 33.7 (9.2–122.3) | ||||
HSRS Total dose/dose per fraction/n fractions | |||||
27 Gy/9 Gy/3 | 51 | 50 | |||
32 Gy/8 Gy/4 | 51 | 50 |